Trials / Completed
CompletedNCT00997347
The Extended Gestational Age Medical Abortion Study
The Extended Gestational Age Medical Abortion Study: The Effectiveness of Medical Abortion With Mifepristone and Misoprostol at 57-63 Days Versus 64-70 Days Gestation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,400 (actual)
- Sponsor
- Gynuity Health Projects · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This open-label, comparative study will compare the efficacy, safety, and acceptability of 200 mg mifepristone followed in 24-48 hours by 800mcg buccal misoprostol or 400mcg sublingual misoprostol for termination of pregnancy in existing outpatient early medical abortion services among women 57-63 days' versus 64-70 days' gestation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mifepristone and misoprostol | 200 mg oral mifepristone 800 mcg buccal misoprostol or 400 mcg sublingual misoprostol 24-48 hours after mifepristone |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2009-10-19
- Last updated
- 2012-07-02
Locations
12 sites across 5 countries: United States, Georgia, India, Tunisia, Ukraine
Source: ClinicalTrials.gov record NCT00997347. Inclusion in this directory is not an endorsement.